APOA1 and chronic kidney disease: This displacement of apoA-1 by SAA is evident in HDL of patients with CHD, end-stage renal disease (ESRD), and sepsis, all of which display increased levels of SAA and decreased levels of apoA-1 in HDL in comparison to healthy controls [55,56,57].